ASCO 2014: Dr. Kipps Discusses Targeted Therapy and Obinutuzumab in the Treatment of CLL (chronic lymphocytic leukemia) in my latest blog post at bkoffman.blogspot.com where I reference the latest research and the data from ASH last December.
ASCO 2014: Dr. Kipps Discusses Targeted Therap... - CLL Support
ASCO 2014: Dr. Kipps Discusses Targeted Therapy and Obinutuzumab
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Targeted therapy drugs
I am interested in people who have taken Zanubrutinib. Did you half to go through a lot of hassle...
ASH 2014. Dr. Sharman discusses the biology of our CLL cells
Friends,
This week on the CLL Society website http://cllsociety.org, we share the first part of an...
ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)
Friends
In another interview from ASH 2013 that I just posted on my blog...
ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance
Venetoclax was changed how we treat CLL, but it doesn't work for everyone and it doesn't always...
ASCO 2016: Dr. Susan O’Brien where she discusses frontline data on Acalabrutinib in CLL
We are 8 weeks out from the 2016 annual meeting of the American Society of Hematology and realize...
Dr Sharman on "Choosing first therapy in CLL"
Obinutuzumab and Venetoclax 
Acalabruitinib and Obinutuzumab 
venetoclax and obinutuzumab
Obinutuzumab and Venetoclax 
